57 related articles for article (PubMed ID: 28819176)
1. Colloidal Stability and Cytotoxicity of Polydopamine-Conjugated Gold Nanorods against Prostate Cancer Cell Lines.
Mahmoud NN; Aqabani H; Hikmat S; Abu-Dahab R
Molecules; 2021 Feb; 26(5):. PubMed ID: 33670890
[TBL] [Abstract][Full Text] [Related]
2. Tuning pharmacokinetics and biodistribution of a targeted drug delivery system through incorporation of a passive targeting component.
Kudgus RA; Walden CA; McGovern RM; Reid JM; Robertson JD; Mukherjee P
Sci Rep; 2014 Jul; 4():5669. PubMed ID: 25011609
[TBL] [Abstract][Full Text] [Related]
3. Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic target.
Maurya PK; Mishra A; Yadav BS; Singh S; Kumar P; Chaudhary A; Srivastava S; Murugesan SN; Mani A
J Cancer; 2017; 8(10):1900-1907. PubMed ID: 28819388
[TBL] [Abstract][Full Text] [Related]
4. Formulation, optimization, in-vivo biodistribution studies and histopathological safety assessment of duloxetine HCl-loaded ultra-elastic nanovesicles for antidepressant effect after intranasal and transdermal delivery.
Abd-Elal RMA; Essawy AM; Salem MA; Elsayed M; Khalil MG; Abdelhakeem E; Ali NA; Tawfik MA
Int J Pharm X; 2023 Dec; 6():100194. PubMed ID: 37434966
[TBL] [Abstract][Full Text] [Related]
5. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.
Yadav P; Ambudkar SV; Rajendra Prasad N
J Nanobiotechnology; 2022 Sep; 20(1):423. PubMed ID: 36153528
[TBL] [Abstract][Full Text] [Related]
6. Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy.
Xu W; Ye C; Qing X; Liu S; Lv X; Wang W; Dong X; Zhang Y
Mater Today Bio; 2022 Dec; 16():100358. PubMed ID: 35880099
[TBL] [Abstract][Full Text] [Related]
7. Comparative Analysis of the Cytotoxic Effect of a Complex of Selenium Nanoparticles Doped with Sorafenib, "Naked" Selenium Nanoparticles, and Sorafenib on Human Hepatocyte Carcinoma HepG2 Cells.
Varlamova EG; Goltyaev MV; Simakin AV; Gudkov SV; Turovsky EA
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743086
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology in the Diagnostic and Therapy of Hepatocellular Carcinoma.
Graur F; Puia A; Mois EI; Moldovan S; Pusta A; Cristea C; Cavalu S; Puia C; Al Hajjar N
Materials (Basel); 2022 May; 15(11):. PubMed ID: 35683190
[TBL] [Abstract][Full Text] [Related]
9. Drug Resistance Reversal Potential of Nanoparticles/Nanocomposites via Antibiotic's Potentiation in Multi Drug Resistant
Pandey P; Sahoo R; Singh K; Pati S; Mathew J; Pandey AC; Kant R; Han I; Choi EH; Dwivedi GR; Yadav DK
Nanomaterials (Basel); 2021 Dec; 12(1):. PubMed ID: 35010068
[TBL] [Abstract][Full Text] [Related]
10. Polymeric Nanocarriers for Effective Synergistic Action of Sorafenib Tosylate and Gold-sensitized Gamma Radiation Against HepG2 Cells.
Sukkar F; Shafaa M; El-Nagdy M; Darwish W
Int J Nanomedicine; 2021; 16():8309-8321. PubMed ID: 34992367
[TBL] [Abstract][Full Text] [Related]
11. Emerging Nano-Based Strategies Against Drug Resistance in Tumor Chemotherapy.
Cao L; Zhu Y; Wang W; Wang G; Zhang S; Cheng H
Front Bioeng Biotechnol; 2021; 9():798882. PubMed ID: 34950650
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib Repurposing for Ophthalmic Delivery by Lipid Nanoparticles: A Preliminary Study.
Bonaccorso A; Pepe V; Zappulla C; Cimino C; Pricoco A; Puglisi G; Giuliano F; Pignatello R; Carbone C
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834371
[TBL] [Abstract][Full Text] [Related]
13. Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy.
Chen F; Fang Y; Chen X; Deng R; Zhang Y; Shao J
Asian J Pharm Sci; 2021 May; 16(3):318-336. PubMed ID: 34276821
[TBL] [Abstract][Full Text] [Related]
14. Successful Synthesis of Gold Nanoparticles through Ultrasonic Spray Pyrolysis from a Gold(III) Nitrate Precursor and Their Interaction with a High Electron Beam.
Shariq M; Friedrich B; Budic B; Hodnik N; Ruiz-Zepeda F; Majerič P; Rudolf R
ChemistryOpen; 2018 Jul; 7(7):533-542. PubMed ID: 30034991
[TBL] [Abstract][Full Text] [Related]
15. Strategies on Nanodiagnostics and Nanotherapies of the Three Common Cancers.
Leng F; Liu F; Yang Y; Wu Y; Tian W
Nanomaterials (Basel); 2018 Mar; 8(4):. PubMed ID: 29597315
[TBL] [Abstract][Full Text] [Related]
16. Use of Biocompatible Sorafenib-gold Nanoconjugates for Reversal of Drug Resistance in Human Hepatoblatoma Cells.
Vishwakarma SK; Sharmila P; Bardia A; Chandrakala L; Raju N; Sravani G; Sastry BVS; Habeeb MA; Khan AA; Dhayal M
Sci Rep; 2017 Aug; 7(1):8539. PubMed ID: 28819176
[TBL] [Abstract][Full Text] [Related]
17. Surface functionalized gold nanoparticles for drug delivery.
Cheng J; Gu YJ; Cheng SH; Wong WT
J Biomed Nanotechnol; 2013 Aug; 9(8):1362-9. PubMed ID: 23926802
[TBL] [Abstract][Full Text] [Related]
18. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo.
Khan JA; Kudgus RA; Szabolcs A; Dutta S; Wang E; Cao S; Curran GL; Shah V; Curley S; Mukhopadhyay D; Robertson JD; Bhattacharya R; Mukherjee P
PLoS One; 2011; 6(6):e20347. PubMed ID: 21738572
[TBL] [Abstract][Full Text] [Related]
19. Colloidal Gold--Collagen Protein Core--Shell Nanoconjugate: One-Step Biomimetic Synthesis, Layer-by-Layer Assembled Film, and Controlled Cell Growth.
Xing R; Jiao T; Yan L; Ma G; Liu L; Dai L; Li J; Möhwald H; Yan X
ACS Appl Mater Interfaces; 2015 Nov; 7(44):24733-40. PubMed ID: 26479181
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
